FDA Issues Draft Guidance for Obtaining Postmarket Data on Underrepresented Populations in Drug Clinical Trials | King & Spalding
The Food and Drug Administration (FDA) has issued new draft guidance, Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological...
United States Drug Administration King Spalding Postmarketing Approaches Obtain Data Populations Underrepresented
Source: jdsupra.com